Genomics companies shop around for chemical expertise
Article Abstract:
Two genomics companies deCODE Genetics and Lexicon Genetics announced significant progress in efforts to strengthen their product pipelines, reassuring dubious investors about genomics companies' commitment and ability to establish genes to drugs platforms that highlighted the need for medicinal chemistry. Details about the different companies who have made a reputation in medicinal chemistry are given.
author: Fletcher, Liz
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
Science & research, Research and Testing Services, Medical Research, Epilepsy & Muscle Disease R&D, Iceland, Administration of Public Health Programs, Health Research Programs, Research, Methods, Product development, Biotechnology industry, Biotechnology industries, deCODE genetics Inc., Genomics, Medicine, Experimental, Lexicon Pharmaceuticals Inc., DCGN
Eli Lilly enter venture capital arena
Article Abstract:
Eli Lilly has created a venture capital group, Lilly BioVentures which will invest up to $75 million in new biotechnology companies. Lilly is one of several pharmaceutical firms making venture capital investments in life science companies.
author: Fletcher, Liz
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2001
Biochemistry, Organizational history, Venture Capital Companies, Miscellaneous Intermediation, Investors, not elsewhere classified, Statistical Data Included, Eli Lilly and Co., LLY, Lilly BioVentures
Cantab failure shows need for wide portfolio
Article Abstract:
With the failure of Cantab's vaccine TH-GW to treat genital warts, the company's stock value has dropped by two thirds, forcing the resignation of CEO Jurek Sikorski, and causing the company to be put up for sale.
author: Fletcher, Liz
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
United Kingdom, Asset sales & divestitures, Sales, profits & dividends, Pharmaceutical Preparation Manufacturing, Executive changes & profiles, Financial analysis, Biological products exc. diagnostic, Vaccines for Human Use, Vaccines, Cantab Pharmaceutical Research Ltd.
subjects list: United States, Drugs
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.